NanoViricides operates a manufacturing facility at 1 Controls Drive, Shelton, Connecticut, which supports drug development activities including design, discovery, chemical synthesis, antiviral evaluation, scale-up, and cGMP-compliant production of drug substances and products. The facility also handles formulation, filling, labeling, packaging, and analytical testing. Clinical trial products NV-CoV-2 Oral Syrup and NV-CoV-2 Oral Gummies were produced at this site and shipped to Karveer Meditech Pvt. Ltd. (KMPL), a collaborator managing clinical trials and commercialization in India. NV-387 Oral Gummies for Phase II Mpox and Ebola clinical trials were shipped to the Democratic Republic of Congo. NanoViricides engages external collaborators, consultants, and subcontractors for regulatory development activities, including animal and safety studies, regulatory strategy, clinical trial design, and documentation. The company holds intellectual property licenses from TheraCour Pharma, Inc.
Nanoviricides Inc's Comment on Supply Chain
NanoViricides operates a manufacturing facility at 1 Controls Drive, Shelton, Connecticut, which supports drug development activities including design, discovery, chemical synthesis, antiviral evaluation, scale-up, and cGMP-compliant production of drug substances and products. The facility also handles formulation, filling, labeling, packaging, and analytical testing. Clinical trial products NV-CoV-2 Oral Syrup and NV-CoV-2 Oral Gummies were produced at this site and shipped to Karveer Meditech Pvt. Ltd. (KMPL), a collaborator managing clinical trials and commercialization in India. NV-387 Oral Gummies for Phase II Mpox and Ebola clinical trials were shipped to the Democratic Republic of Congo. NanoViricides engages external collaborators, consultants, and subcontractors for regulatory development activities, including animal and safety studies, regulatory strategy, clinical trial design, and documentation. The company holds intellectual property licenses from TheraCour Pharma, Inc.
Sources:
Nanoviricides inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Nanoviricides inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
